Kent Emry - 31 Dec 2021 Form 4 Insider Report for BioCorRx Inc. (BICX)

Role
Director
Signature
/s/ Kent Emry
Issuer symbol
BICX
Transactions as of
31 Dec 2021
Transactions value $
$0
Form type
4
Filing time
04 Apr 2022, 17:30:10 UTC
Previous filing
25 Oct 2021
Next filing
06 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BICX Common Stock, par value $0.001 Award $0 +1,141 +1.23% $0 94,223 31 Dec 2021 Direct F1
transaction BICX Common Stock, par value $0.001 Award $0 +1,408 +1.49% $0 95,631 31 Mar 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were issued to Mr. Emry pursuant to a Director Agreement, dated March 1, 2019, by and between BioCorRx Inc. and Mr. Emry. As compensation for his services, Mr. Emry shall be issued, upon the last day of each fiscal quarter, provided Mr. Emry is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $4.38.
F2 These shares were issued to Mr. Emry pursuant to the Director Agreement referenced in footnote 1. The average closing price on the three trading days immediately preceding the date of this transaction was $3.55.